Reyvow
Chemical Name | lasmiditan |
Dosage Form | Tablet (oral; 50 mg, 100 mg) |
Drug Class | Receptor agonists |
System | Nervous |
Company | Eli Lilly and Company |
Approval Year | 2020 |
Indication
- Reyvow is indicated for the acute treatment of migraine with or without aura in adults.